Molecular CellBiochemistryPeer-reviewed journal article
Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity
Tigist Y. TamiriD, Shreya Chaudhary, Annie X LiiD, S. E. TrojaniD, Cameron T. FloweriD, Paula VoiD, Yufei CuiiD, Jeffrey C DavisiD, Rachit S Mukkamala, Francesca N VendittiiD, Alissandra L. HillisiD, Alex TokeriD, Matthew G. Vander HeideniD, Jessica B. SpinelliiD, Norman J. Kennedy, Roger J. DavisiD, Forest M. WhiteiD
Abstract
Coordination of adaptive metabolism through cellular signaling networks and metabolic response is essential for balanced flow of energy and homeostasis. Post-translational modifications such as phosphorylation offer a rapid, efficient, and dynamic mechanism to regulate metabolic networks. Although numerous phosphorylation sites have been identified on metabolic enzymes, much remains unknown about their contribution to enzyme function and systemic metabolism. In this study, we stratify phosphorylation sites on metabolic enzymes based on their location with respect to functional and dimerization domains. Our analysis reveals that the majority of published phosphosites are on oxidoreductases, with particular enrichment of phosphotyrosine (pY) sites in proximity to binding domains for substrates, cofactors, active sites, or dimer interfaces. We identify phosphosites altered in obesity using a high fat diet (HFD) induced obesity model coupled to multiomics, and interrogate the functional impact of pY on hepatic metabolism. HFD induced dysregulation of redox homeostasis and reductive metabolism at the phosphoproteome and metabolome level in a sex-specific manner, which was reversed by supplementing with the antioxidant butylated hydroxyanisole (BHA). Partial least squares regression (PLSR) analysis identified pY sites that predict HFD or BHA induced changes of redox metabolites. We characterize predictive pY sites on glutathione S-transferase pi 1 (GSTP1), isocitrate dehydrogenase 1 (IDH1), and uridine monophosphate synthase (UMPS) using CRISPRi-rescue and stable isotope tracing. Our analysis revealed that sites on GSTP1 and UMPS inhibit enzyme activity while the pY site on IDH1 induces activity to promote reductive carboxylation. Overall, our approach provides insight into the convergence points where cellular signaling fine-tunes metabolism. Summary StatementBy employing a multi-disciplinary approach we stratify structural features of phosphorylation sites on metabolic enzymes, map the systems level changes induced by obesity, identify key pathways with sex specific phosphoproteomic responses, and validate the functional role of phosphorylation sites for select enzymes.
- organism: mouse
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 8
- FWCI
- 0.92
- Field percentile
- top 28%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Parallel phosphoproteomics and metabolomics map the global metabolic tyrosine phosphoproteome
Alissandra L. Hillis, Tigist Y. Tamir, … Alex Toker·Proceedings of the National Academy of SciencesPeer-reviewed·Nov 13, 2024
- Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells
Emanuel Gonçalves, Marco Sciacovelli, … Julio Sáez-Rodríguez·Metabolic EngineeringPeer-reviewed·Nov 27, 2017
- Multi-omics approach reveals dysregulation of protein phosphorylation correlated with lipid metabolism in mouse fatty liver
Sora Q. Kim, Rodrigo Mohallem, … Uma K. Aryal·bioRxiv·Feb 16, 2022
- Protein tyrosine phosphatase receptor kappa regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity
E. H. Gilglioni, A. Li, … E. N. Gurzov·bioRxiv·Dec 1, 2023
- Hepatic aldose reductase drives a Warburg effect-like metabolic reprogramming to promote insulin resistance, fatty liver and obesity
Dan Song, Dianqiang Yang, … James Y. Yang·bioRxiv·Sep 23, 2024
- Inhibition of mammalian mtDNA transcription paradoxically activates liver fatty acid oxidation to reverse diet-induced hepatosteatosis and obesity
S. Jiang, T. Yuan, … N.-G. Larsson·bioRxiv·Sep 22, 2023